403 related articles for article (PubMed ID: 34561086)
1. Estimating salivary carriage of severe acute respiratory syndrome coronavirus 2 in nonsymptomatic people and efficacy of mouthrinse in reducing viral load: A randomized controlled trial.
Chaudhary P; Melkonyan A; Meethil A; Saraswat S; Hall DL; Cottle J; Wenzel M; Ayouty N; Bense S; Casanova F; Chaney M; Chase H; Hermel R; McClement M; Sesson C; Woolsey B; Kumar P
J Am Dent Assoc; 2021 Nov; 152(11):903-908. PubMed ID: 34561086
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the effect of gargling with hydrogen peroxide and povidone-iodine on salivary viral load of SARS-CoV-2: A pilot randomized clinical trial.
Adl A; Sedigh-Shams M; Jamalidoust M; Rajabzadeh Z
Niger J Clin Pract; 2023 Apr; 26(4):391-396. PubMed ID: 37203101
[TBL] [Abstract][Full Text] [Related]
3. The effect of mouthrinses on severe acute respiratory syndrome coronavirus 2 viral load: A systematic review.
Silva A; Azevedo M; Sampaio-Maia B; Sousa-Pinto B
J Am Dent Assoc; 2022 Jul; 153(7):635-648.e16. PubMed ID: 35287944
[TBL] [Abstract][Full Text] [Related]
4. In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial.
Elzein R; Abdel-Sater F; Fakhreddine S; Hanna PA; Feghali R; Hamad H; Ayoub F
J Evid Based Dent Pract; 2021 Sep; 21(3):101584. PubMed ID: 34479668
[TBL] [Abstract][Full Text] [Related]
5. Mouth rinses efficacy on salivary SARS-CoV-2 viral load: A randomized clinical trial.
Alzahrani MM; Bamashmous S; Alkharobi H; Alghamdi A; Alharbi RH; Hassan AM; Darwish M; Bukhari A; Mahmoud AB; Alfaleh MA; Mirza AA; Abuzenadah AM; Abujamel TS; Hashem AM
J Med Virol; 2023 Jan; 95(1):e28412. PubMed ID: 36527332
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of three antimicrobial mouthwashes in reducing SARS-CoV-2 viral load in the saliva of hospitalized patients: a randomized controlled pilot study.
Perussolo J; Teh MT; Gkranias N; Tiberi S; Petrie A; Cutino-Moguel MT; Donos N
Sci Rep; 2023 Aug; 13(1):12647. PubMed ID: 37542087
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore.
Seneviratne CJ; Balan P; Ko KKK; Udawatte NS; Lai D; Ng DHL; Venkatachalam I; Lim KS; Ling ML; Oon L; Goh BT; Sim XYJ
Infection; 2021 Apr; 49(2):305-311. PubMed ID: 33315181
[TBL] [Abstract][Full Text] [Related]
8. A quadruple blind, randomised controlled trial of gargling agents in reducing intraoral viral load among hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.
Khan FR; Kazmi SMR; Iqbal NT; Iqbal J; Ali ST; Abbas SA
Trials; 2020 Sep; 21(1):785. PubMed ID: 32928313
[TBL] [Abstract][Full Text] [Related]
9. Povidone-Iodine as a Pre-Procedural Mouthwash to Reduce the Salivary Viral Load of SARS-CoV-2: A Systematic Review of Randomized Controlled Trials.
Garcia-Sanchez A; Peña-Cardelles JF; Ordonez-Fernandez E; Montero-Alonso M; Kewalramani N; Salgado-Peralvo AO; Végh D; Gargano A; Parra G; Guerra-Guajardo LI; Kozuma W
Int J Environ Res Public Health; 2022 Mar; 19(5):. PubMed ID: 35270569
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of mouthwash on reducing salivary SARS-CoV-2 viral load and clinical symptoms: a systematic review and meta-analysis.
Zhang M; Meng N; Duo H; Yang Y; Dong Q; Gu J
BMC Infect Dis; 2023 Oct; 23(1):678. PubMed ID: 37821800
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of mouthrinses in reducing oral SARS-COV-2 load: a review.
Pannuti CM; Reis INRD; Souza NV; Souto MLS; Silva CGB; Bezinelli LM; Machado CM; Romito GA; Villar CC
Braz Oral Res; 2023; 37():e038. PubMed ID: 37132726
[TBL] [Abstract][Full Text] [Related]
12. Can preprocedural mouthrinses reduce SARS-CoV-2 load in dental aerosols?
Reis INR; do Amaral GCLS; Mendoza AAH; das Graças YT; Mendes-Correa MC; Romito GA; Pannuti CM
Med Hypotheses; 2021 Jan; 146():110436. PubMed ID: 33288313
[TBL] [Abstract][Full Text] [Related]
13. Salivary and Nasal Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses (BBCovid): A structured summary of a study protocol for a randomised controlled trial.
Carrouel F; Viennot S; Valette M; Cohen JM; Dussart C; Bourgeois D
Trials; 2020 Nov; 21(1):906. PubMed ID: 33138848
[TBL] [Abstract][Full Text] [Related]
14. Reduction of SARS-CoV-2 salivary viral load with pre-procedural mouth rinses: a randomised, controlled, clinical trial.
Farmaha JK; James JN; Frazier K; Sahajpal NS; Mondal AK; Bloomquist DT; Kolhe R; Looney SW; Bloomquist R
Br Dent J; 2023 Apr; 234(8):593-600. PubMed ID: 37117367
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of antiseptic mouth rinses to reduce salivary load of SARS-CoV-2.
Ferrer MD; Barrueco ÁS; Martinez-Beneyto Y; Mateos-Moreno MV; Ausina-Márquez V; García-Vázquez E; Puche-Torres M; Giner MJF; González AC; Coello JMS; Rueda IA; Aubá JMV; Español CC; Velasco AL; Abad DS; García-Esteban S; Artacho A; López-Labrador X; Mira A
Sci Rep; 2021 Dec; 11(1):24392. PubMed ID: 34937855
[TBL] [Abstract][Full Text] [Related]
16. The short-term effect of different chlorhexidine forms versus povidone iodine mouth rinse in minimizing the oral SARS-CoV-2 viral load: An open label randomized controlled clinical trial study.
Natto ZS; Bakhrebah MA; Afeef M; Al-Harbi S; Nassar MS; Alhetheel AF; Ashi H
Medicine (Baltimore); 2022 Jul; 101(30):e28925. PubMed ID: 35905275
[TBL] [Abstract][Full Text] [Related]
17. Use of an antiviral mouthwash as a barrier measure in the SARS-CoV-2 transmission in adults with asymptomatic to mild COVID-19: a multicentre, randomized, double-blind controlled trial.
Carrouel F; Valette M; Gadea E; Esparcieux A; Illes G; Langlois ME; Perrier H; Dussart C; Tramini P; Ribaud M; Bouscambert-Duchamp M; Bourgeois D
Clin Microbiol Infect; 2021 Oct; 27(10):1494-1501. PubMed ID: 34044151
[TBL] [Abstract][Full Text] [Related]
18. A prospective clinical pilot study on the effects of a hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2.
Gottsauner MJ; Michaelides I; Schmidt B; Scholz KJ; Buchalla W; Widbiller M; Hitzenbichler F; Ettl T; Reichert TE; Bohr C; Vielsmeier V; Cieplik F
Clin Oral Investig; 2020 Oct; 24(10):3707-3713. PubMed ID: 32876748
[TBL] [Abstract][Full Text] [Related]
19. Reducing the viral load of SARS-CoV-2 in the saliva of patients with COVID-19.
Guimarães TC; Marques BBF; Castro MV; Secco DA; Porto LCMS; Tinoco JMM; Tinoco EMB; Fletcher P; Fischer RG
Oral Dis; 2022 Nov; 28 Suppl 2():2474-2480. PubMed ID: 34963033
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of a High SARS-CoV-2 Viral Load in the Saliva.
Yoon JG; Yoon J; Song JY; Yoon SY; Lim CS; Seong H; Noh JY; Cheong HJ; Kim WJ
J Korean Med Sci; 2020 May; 35(20):e195. PubMed ID: 32449329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
